RS52219B - Pozologija kladribina za tretiranje multiple skleroze - Google Patents

Pozologija kladribina za tretiranje multiple skleroze

Info

Publication number: RS52219B
Authority: RS; Serbia
Prior art keywords: cladribine; months; period; pharmaceutical formulation; administered
Prior art date: 2004-12-22

Application number

RS20120161A

Other languages

English (en)

Serbian (sr)

Inventor

Giampiero De Luca

Arnaud Ythier

Alain Munafo

Maria Lopez-Bresnahan

Original Assignee

Merck Serono Sa.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-22

Filing date

2005-12-20

Publication date

2012-10-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34930135&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS52219(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-12-20 Application filed by Merck Serono Sa. filed Critical Merck Serono Sa.

2005-12-20 Priority claimed from PCT/EP2005/056954 external-priority patent/WO2006067141A1/en

2012-10-31 Publication of RS52219B publication Critical patent/RS52219B/sr

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)
Chemical And Physical Treatments For Wood And The Like (AREA)
Pressure Welding/Diffusion-Bonding (AREA)

RS20120161A 2004-12-22 2005-12-20 Pozologija kladribina za tretiranje multiple skleroze RS52219B (sr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US63866904P	2004-12-22	2004-12-22
EP04106909		2004-12-22
PCT/EP2005/056954 WO2006067141A1 (en)	2004-12-22	2005-12-20	Cladribine regimen for treating multiple sclerosis

Publications (1)

Publication Number	Publication Date
RS52219B true RS52219B (sr)	2012-10-31

Family

ID=34930135

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
RS20120161A RS52219B (sr)	2004-12-22	2005-12-20	Pozologija kladribina za tretiranje multiple skleroze

Country Status (11)

Country	Link
AT (1)	ATE547106T1 (de)
CY (1)	CY1125491T1 (de)
DK (1)	DK1827461T3 (de)
ES (4)	ES2666146T3 (de)
HU (1)	HUE035859T2 (de)
LT (1)	LT2805723T (de)
ME (1)	ME01333B (de)
PT (4)	PT1827461E (de)
RS (1)	RS52219B (de)
SI (1)	SI1827461T1 (de)
UA (1)	UA96260C2 (de)

2005
- 2005-12-20 RS RS20120161A patent/RS52219B/sr unknown
- 2005-12-20 AT AT05823474T patent/ATE547106T1/de active
- 2005-12-20 DK DK05823474.1T patent/DK1827461T3/da active
- 2005-12-20 UA UAA200708371A patent/UA96260C2/ru unknown
- 2005-12-20 ES ES14001970.4T patent/ES2666146T3/es not_active Expired - Lifetime
- 2005-12-20 PT PT05823474T patent/PT1827461E/pt unknown
- 2005-12-20 SI SI200531514T patent/SI1827461T1/sl unknown
- 2005-12-20 LT LTEP14001970.4T patent/LT2805723T/lt unknown
- 2005-12-20 ES ES10182676.6T patent/ES2495392T3/es not_active Expired - Lifetime
- 2005-12-20 PT PT181516345T patent/PT3332789T/pt unknown
- 2005-12-20 PT PT221666100T patent/PT4070800T/pt unknown
- 2005-12-20 ES ES05823474T patent/ES2382554T3/es not_active Expired - Lifetime
- 2005-12-20 PT PT140019704T patent/PT2805723T/pt unknown
- 2005-12-20 HU HUE14001970A patent/HUE035859T2/en unknown
- 2005-12-20 ES ES10182632T patent/ES2428741T3/es not_active Expired - Lifetime
- 2005-12-20 ME MEP-2012-35A patent/ME01333B/me unknown
2022
- 2022-06-21 CY CY20221100424T patent/CY1125491T1/el unknown

Also Published As

Publication number	Publication date
ES2666146T3 (es)	2018-05-03
SI1827461T1 (sl)	2012-05-31
HUE035859T2 (en)	2018-05-28
LT2805723T (lt)	2018-02-12
DK1827461T3 (da)	2012-03-26
ES2495392T3 (es)	2014-09-17
PT3332789T (pt)	2022-07-05
CY1125491T1 (el)	2025-05-09
ES2428741T3 (es)	2013-11-11
PT2805723T (pt)	2018-01-25
UA96260C2 (ru)	2011-10-25
PT1827461E (pt)	2012-05-07
ES2382554T3 (es)	2012-06-11
PT4070800T (pt)	2024-12-30
ME01333B (me)	2013-12-20
ATE547106T1 (de)	2012-03-15

Publication	Publication Date	Title
US8377903B2 (en)	2013-02-19	Cladribine regimen for treating multiple sclerosis
HK40083827A (en)	2023-07-07	Cladribine regimen for treating multiple sclerosis
HK40083827B (en)	2025-03-21	Cladribine regimen for treating multiple sclerosis
ES2382554T3 (es)	2012-06-11	Pauta posológica de cladribina para el tratamiento de la esclerosis múltiple
CN101090726A (zh)	2007-12-19	治疗多发性硬化的克拉屈滨方案
HK1110517A (en)	2008-07-18	Cladribine regimen for treating multiple sclerosis